logo
Email For Us
Mazdutide
<
>
Mazdutide
Mazdutide

Mazdutide

Lithium Hydroxide


Description

Basic Info.


Mazdutide is a dual  agonist  of the GLP-1receptor and glucagon receptor. It is an analog of oxyntomodulin (OXM). 

The drug is developed by Eli Lilly and is currently in multiple Phase III studies.


 In May 2025, a result of Phase III study has shown that once-weekly mazdutide led to clinically relevant reductions in body weight in Chinese adults with overweight or obesity.


“Strength builds the foundation, and excellent services reach all over the world.”

We have cooperated with experienced shipping forwarders for many years, they arrange the shipment. No matter by express, by air or by sea, we will track the course of the goods all the way, to make sure goods arrive at you on time and in good condition.




GET A QUOTE

Whether you have any questions about our products, please feel free to contact us, we will reply as soon as possible.
Adhering to the service tenet of "Integrity, Innovation, Harmony, and Win-win", We have established a complete one-stop procurement and comprehensive solution service system.

GET IN TOUCH!

© Shenzhen Yuanyang Biotechnology Co., LTD All Rights Reserved.